The Dr Trust Bestest Compressor Nebulizer is a highly efficient and reliable device for home use. It features a powerful ...
The Pneumatic Nebulizer market is expected to grow from an estimated USD 815.5 million in 2024 to USD 1.47 billion in 2033, at a CAGR of 6.80% VANCOUVER, BRITISH COLUMBIA, CANADA, January 16, 2025 ...
But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.
Fexlamose is a potent and fast acting mucolytic that is well-suited for pulmonary delivery as liquid inhalation solution by ...
Approximately $36 million and $42 million net product sales of Ohtuvayre for the fourth quarter and full year 2024, ...
The NE-U22V MicroAir®, the world’s smallest nebulizer utilizing Vibrating Mesh Technology (V.M.T.), efficiently delivers solution medications for patients suffering from asthma, COPD or other ...
Verona Pharma stock hit a record high Thursday on continued enthusiasm for its newly launched COPD treatment, Ohtuvayre.
The Company continues to anticipate that the totality of its early-stage research programs will comprise less than 20% of overall expenditure.
Liquidia Corporation (NASDAQ: LQDA) announced today that Dr. Roger Jeffs, Chief Executive Officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025, ...
Coughing is a natural reflex action that helps clear the airways of irritants, mucus, smoke, dust, or allergens. While most ...
Ohtuvayre showed significant improvement in lung function by 12 weeks. Follow-up analyses showed that Ohtuvayre had long-term ...